4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Complex Exercise Intervention to Normalize Blood Pressure and Nocturnal Dipping in Patients With Hypertension (END-HT)

Complex Exercise Intervention to Normalize Blood Pressure and Nocturnal Dipping in Patients With Hypertension (END-HT)

Study Description
Brief Summary:

Background: Non-dipping hypertension(HT) (as defined by lack of decrease in systolic blood pressure (BP) by 10% during sleep) predicts cardiovascular events and mortality; however, there is a lack of evidence based treatment for non-dipping HT. While exercise is recommended to management HT, its effect on dipping status is not known. There is a lack of trials describing the relationship of exercise and blood pressure in Chinese.

Method: This will be a two-arm randomized controlled trial in which Chinese non-dippers (n= 198) will be randomized to an exercise program plus usual care or to usual care by stratified randomization. The randomization sequence is blinded to the investigators and allocation is disclosed only after valid consent. The exercise program utilizes various motivational techniques to enhance exercise maintenance.


Condition or disease Intervention/treatment Phase
Hypertension Behavioral: EIM intervention group Not Applicable

Study Design
Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 198 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Masking Description: The statistician will be masked
Primary Purpose: Treatment
Official Title: Effectiveness of a Complex Exercise Intervention to Normalize Blood Pressure and Its Nocturnal Dipping in Patients With HyperTension in Primary Care: a Randomized-controlled Trial
Estimated Study Start Date : March 1, 2021
Estimated Primary Completion Date : September 30, 2023
Estimated Study Completion Date : December 31, 2023
Arms and Interventions
Arm Intervention/treatment
Experimental: EIM group
patients with Hypertension (HT) will be recruited by a trained nurse when the patient attends the yearly to bi-yearly complication screening program called the risk assessment and management program (RAMP) program. This program is provided to all patients with HT, who are seen in the Government-funded primary care clinics in Hong Kong. The nurse will encourage the patient by motivational interviewing techniques and prescribe exercise. Combined exercise skills will be taught in the 12-week weekly exercise classes by certified physical trainers. Peer support is encouraged during and after the 12-week program. Regular feedback, prompting and problem solving will be provided by the nurse at 3m, 6m, and 12m. Exercise level will be monitored by validated wrist trackers to feedback participants, nurse and physical trainer by mobile apps and website. Resources to exercise will be made known to patients by apps, website and healthcare professionals.
Behavioral: EIM intervention group
As in arm description

No Intervention: usual care
There is no extra intervention to patients allocated in this arm, except that they receive information and advice on lifestyle changes including benefits from exercise from the nurse at recruitment as stated above. Participants in both arms will have no changes in medication within the first 12-week to determine the BP difference between the two groups. In Hong Kong, patients have unlimited access to emergency department and general outpatient services. All patients with HT receive RAMP program counselling and screening every 1-2 years. These are not limited by the current trial.
Outcome Measures
Primary Outcome Measures :
  1. systolic blood pressure(SBP) dipping status [ Time Frame: at 12-week, after the EIM program ]
    as defined by a lack of SBP drop of more than 10% during sleep, as detected by ambulatory blood pressure measurements (ABPM)


Secondary Outcome Measures :
  1. daytime, night-time, 24-h SBP, and DBP [ Time Frame: baseline (before the 12-week program ), at 12 weeks and 12 months after recruitment ]
    as detected on ABPM discussed above

  2. serum lipid profile [ Time Frame: baseline (before the 12-week program ), at 12 weeks and 12 months after recruitment ]
    this includes serum total cholesterol, triglyceride , low-density lipoprotein and high-density lipoprotein

  3. body mass index [ Time Frame: baseline (before the 12-week program ), at 12 weeks, at 24 weeks and 12 months after recruitment ]
    weight and height will be combined to report BMI in kg/m^2

  4. office blood pressure [ Time Frame: baseline (before the 12-week program ), at 12 weeks, at 24 weeks and 12 months after recruitment ]
    office blood pressure will be measured 3 times and the last 2 will be averaged as the outcome

  5. The Chinese version of international Physical Activity Questionnaire - short form (IPAQ-SF) [ Time Frame: baseline (before the 12-week program ), at 12 weeks, at 24 weeks and 12 months after recruitment ]
    a validated questionnaire to detect exercise level; The questionnaire can provide the amount of time the participant spend on moderate or vigorous physical activities. The amount of energy spent can be calculated (metabolic equivalent of task; MET). For example, high level of exercise can be defined as a minimum total physical activity of at least 3000 MET minutes a week. The higher the MET, the higher the exercise level

  6. systolic blood pressure(SBP) dipping status [ Time Frame: measured at baseline and 12 months ]
    as defined by a lack of SBP drop of more than 10% during sleep, as detected by ambulatory blood pressure measurements (ABPM)

  7. body fat percentage [ Time Frame: baseline (before the 12-week program ), at 12 weeks, at 24 weeks and 12 months after recruitment ]
    body fat percentage

  8. serum fasting glucose level [ Time Frame: baseline (before the 12-week program ), at 12 weeks and 12 months after recruitment ]
    serum fasting glucose level

  9. serum creatinine level [ Time Frame: baseline (before the 12-week program ), at 12 weeks and 12 months after recruitment ]
    serum creatinine level that reflects renal function

  10. waist circumference [ Time Frame: baseline (before the 12-week program ), at 12 weeks and 12 months after recruitment ]
    waist circumference

  11. serum high sensitive C-reactive protein [ Time Frame: baseline (before the 12-week program ), at 12 weeks and 12 months after recruitment ]
    serum high sensitive C-reactive protein that reflect the degree of inflammation

  12. MRI (proton density fat fraction) [ Time Frame: baseline (before the 12 week program), at 12 weeks ]
    MRI liver to detect the degree of liver steatosis

  13. Pittsburgh Sleep Quality Index(PSQI) [ Time Frame: baseline (before the 12-week program ), at 12 weeks, at 24 weeks and 12 months after recruitment ]
    a validated questionnaire to detect sleep quality; possible "global" score include can range from 0 to 21. A global score of 5 or more indicates poor sleep quality; the higher the score, the worse the quality.

  14. STOP-BANG (Snoring, Tiredness, Observed apnea, Blood pressure, Body mass index, Age, Neck circumference and Gender) questionnaire [ Time Frame: baseline (before the 12-week program ), at 12 weeks, at 24 weeks and 12 months after recruitment ]
    a validated questionnaire to detect presence of sleep apnea; any 3 positive items from the 8 questions as having risk of OSA; the higher the number of positive items, the higher the risk


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • SBP non-dippers
  • self-reported exercise intensity and duration less than the World Health Organization recommendation, which is exercise of moderate intensity less than 150minutes/week OR exercise of vigorous intensity of less than 75 minutes/week
  • Used any mobile apps on their phone (because the intervention involve use of apps to monitor and remind regular exercise)

Exclusion Criteria

  • Patients with diagnosed chronic obstructive lung disease and recent stroke (within last 12 months) because other evidence-proven and well-structured programmes are implemented for these patients in the hospital authority in Hong Kong
  • Occupational drivers - because they need to hold their arm still during ABPM and this may be hazardous for drivers

    • night-time workers
    • diagnosed Obstructive Sleep Apnea
  • Patients on anti-coagulants - because ABPM may induce bruises
  • Patients on 3 or more medications for hypertension (on maximum tolerable doses) - these patients may have secondary HT and represent a different spectrum of organic diseases
  • Patients with SBP >180mmHg or DBP >110mmHg - drug titration is not allowed during the 12-week program and these patients need early drug treatment
  • Patient with DM - these patients will be arranged to have another EIM program especially designed for their DM.

    • Patients with active spinal cord compression or spinal radiculopathy because they may not be suitable to join some exercise
    • patients with atrial fibrillation are excluded because these patients have increased BP variability and may have different dipping behaviour
    • patients with metallic implants or pacemakers are excluded as they are not suitable for MRI
  • To maximize safety of patients, patients who are relatively contraindicated according to AHA will also be excluded

    • acute myocardial infarction in last 6 months
    • ongoing angina
    • uncontrolled cardiac arrhythmia
    • acute diseases including known active endocarditis/acute pulmonary embolism, pulmonary infarction, deep vein thrombosis, acute aortic dissection, acute myocarditis
    • known aortic stenosis
    • known heart failure
    • known obstructive left main coronary artery stenosis
    • uncontrolled ventricular rates
    • complete heart block
    • known hypertrophic obstructive cardiomyopathy
    • mental impairment that limit co-operation
    • resting blood pressure with systolic blood pressure >180mmHg or diastolic blood pressure >110mmHg
    • known anemia with hemoglobin level less than 11gm/dL
    • known uncorrected electrolyte imbalance, and
    • known uncontrolled hyperthyroidism.
Contacts and Locations

Contacts
Layout table for location contacts
Contact: Kam Pui Lee, MSc 2252 8562 lkp032@cuhk.edu.hk

Locations
Layout table for location information
Hong Kong
Lek Yuen Clinic
Hong Kong, Hong Kong
Sponsors and Collaborators
Chinese University of Hong Kong
Tracking Information
First Submitted Date  ICMJE April 16, 2019
First Posted Date  ICMJE April 23, 2019
Last Update Posted Date January 28, 2021
Estimated Study Start Date  ICMJE March 1, 2021
Estimated Primary Completion Date September 30, 2023   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: April 18, 2019)
systolic blood pressure(SBP) dipping status [ Time Frame: at 12-week, after the EIM program ]
as defined by a lack of SBP drop of more than 10% during sleep, as detected by ambulatory blood pressure measurements (ABPM)
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: January 26, 2021)
  • daytime, night-time, 24-h SBP, and DBP [ Time Frame: baseline (before the 12-week program ), at 12 weeks and 12 months after recruitment ]
    as detected on ABPM discussed above
  • serum lipid profile [ Time Frame: baseline (before the 12-week program ), at 12 weeks and 12 months after recruitment ]
    this includes serum total cholesterol, triglyceride , low-density lipoprotein and high-density lipoprotein
  • body mass index [ Time Frame: baseline (before the 12-week program ), at 12 weeks, at 24 weeks and 12 months after recruitment ]
    weight and height will be combined to report BMI in kg/m^2
  • office blood pressure [ Time Frame: baseline (before the 12-week program ), at 12 weeks, at 24 weeks and 12 months after recruitment ]
    office blood pressure will be measured 3 times and the last 2 will be averaged as the outcome
  • The Chinese version of international Physical Activity Questionnaire - short form (IPAQ-SF) [ Time Frame: baseline (before the 12-week program ), at 12 weeks, at 24 weeks and 12 months after recruitment ]
    a validated questionnaire to detect exercise level; The questionnaire can provide the amount of time the participant spend on moderate or vigorous physical activities. The amount of energy spent can be calculated (metabolic equivalent of task; MET). For example, high level of exercise can be defined as a minimum total physical activity of at least 3000 MET minutes a week. The higher the MET, the higher the exercise level
  • systolic blood pressure(SBP) dipping status [ Time Frame: measured at baseline and 12 months ]
    as defined by a lack of SBP drop of more than 10% during sleep, as detected by ambulatory blood pressure measurements (ABPM)
  • body fat percentage [ Time Frame: baseline (before the 12-week program ), at 12 weeks, at 24 weeks and 12 months after recruitment ]
    body fat percentage
  • serum fasting glucose level [ Time Frame: baseline (before the 12-week program ), at 12 weeks and 12 months after recruitment ]
    serum fasting glucose level
  • serum creatinine level [ Time Frame: baseline (before the 12-week program ), at 12 weeks and 12 months after recruitment ]
    serum creatinine level that reflects renal function
  • waist circumference [ Time Frame: baseline (before the 12-week program ), at 12 weeks and 12 months after recruitment ]
    waist circumference
  • serum high sensitive C-reactive protein [ Time Frame: baseline (before the 12-week program ), at 12 weeks and 12 months after recruitment ]
    serum high sensitive C-reactive protein that reflect the degree of inflammation
  • MRI (proton density fat fraction) [ Time Frame: baseline (before the 12 week program), at 12 weeks ]
    MRI liver to detect the degree of liver steatosis
  • Pittsburgh Sleep Quality Index(PSQI) [ Time Frame: baseline (before the 12-week program ), at 12 weeks, at 24 weeks and 12 months after recruitment ]
    a validated questionnaire to detect sleep quality; possible "global" score include can range from 0 to 21. A global score of 5 or more indicates poor sleep quality; the higher the score, the worse the quality.
  • STOP-BANG (Snoring, Tiredness, Observed apnea, Blood pressure, Body mass index, Age, Neck circumference and Gender) questionnaire [ Time Frame: baseline (before the 12-week program ), at 12 weeks, at 24 weeks and 12 months after recruitment ]
    a validated questionnaire to detect presence of sleep apnea; any 3 positive items from the 8 questions as having risk of OSA; the higher the number of positive items, the higher the risk
Original Secondary Outcome Measures  ICMJE
 (submitted: April 18, 2019)
  • daytime, night-time, 24-h SBP, and DBP [ Time Frame: baseline (before the 12-week program ), at 12 weeks and 12 months after recruitment ]
    as detected on ABPM discussed above
  • serum lipid profile [ Time Frame: baseline (before the 12-week program ), at 12 weeks and 12 months after recruitment ]
    this includes serum total cholesterol, triglyceride , low-density lipoprotein and high-density lipoprotein
  • body mass index [ Time Frame: baseline (before the 12-week program ), at 12 weeks, at 24 weeks and 12 months after recruitment ]
    weight and height will be combined to report BMI in kg/m^2
  • office blood pressure [ Time Frame: baseline (before the 12-week program ), at 12 weeks, at 24 weeks and 12 months after recruitment ]
    office blood pressure will be measured 3 times and the last 2 will be averaged as the outcome
  • Godin-Shephard Leisure-Time Physical Activity Questionnaire (GSLTPAQ) [ Time Frame: baseline (before the 12-week program ), at 12 weeks, at 24 weeks and 12 months after recruitment ]
    a validated questionnaire to detect exercise level
  • systolic blood pressure(SBP) dipping status [ Time Frame: measured at baseline and 12 months ]
    as defined by a lack of SBP drop of more than 10% during sleep, as detected by ambulatory blood pressure measurements (ABPM)
  • body fat percentage [ Time Frame: baseline (before the 12-week program ), at 12 weeks, at 24 weeks and 12 months after recruitment ]
    body fat percentage
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Complex Exercise Intervention to Normalize Blood Pressure and Nocturnal Dipping in Patients With Hypertension
Official Title  ICMJE Effectiveness of a Complex Exercise Intervention to Normalize Blood Pressure and Its Nocturnal Dipping in Patients With HyperTension in Primary Care: a Randomized-controlled Trial
Brief Summary

Background: Non-dipping hypertension(HT) (as defined by lack of decrease in systolic blood pressure (BP) by 10% during sleep) predicts cardiovascular events and mortality; however, there is a lack of evidence based treatment for non-dipping HT. While exercise is recommended to management HT, its effect on dipping status is not known. There is a lack of trials describing the relationship of exercise and blood pressure in Chinese.

Method: This will be a two-arm randomized controlled trial in which Chinese non-dippers (n= 198) will be randomized to an exercise program plus usual care or to usual care by stratified randomization. The randomization sequence is blinded to the investigators and allocation is disclosed only after valid consent. The exercise program utilizes various motivational techniques to enhance exercise maintenance.

Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Masking Description:
The statistician will be masked
Primary Purpose: Treatment
Condition  ICMJE Hypertension
Intervention  ICMJE Behavioral: EIM intervention group
As in arm description
Study Arms  ICMJE
  • Experimental: EIM group
    patients with Hypertension (HT) will be recruited by a trained nurse when the patient attends the yearly to bi-yearly complication screening program called the risk assessment and management program (RAMP) program. This program is provided to all patients with HT, who are seen in the Government-funded primary care clinics in Hong Kong. The nurse will encourage the patient by motivational interviewing techniques and prescribe exercise. Combined exercise skills will be taught in the 12-week weekly exercise classes by certified physical trainers. Peer support is encouraged during and after the 12-week program. Regular feedback, prompting and problem solving will be provided by the nurse at 3m, 6m, and 12m. Exercise level will be monitored by validated wrist trackers to feedback participants, nurse and physical trainer by mobile apps and website. Resources to exercise will be made known to patients by apps, website and healthcare professionals.
    Intervention: Behavioral: EIM intervention group
  • No Intervention: usual care
    There is no extra intervention to patients allocated in this arm, except that they receive information and advice on lifestyle changes including benefits from exercise from the nurse at recruitment as stated above. Participants in both arms will have no changes in medication within the first 12-week to determine the BP difference between the two groups. In Hong Kong, patients have unlimited access to emergency department and general outpatient services. All patients with HT receive RAMP program counselling and screening every 1-2 years. These are not limited by the current trial.
Publications * Lee EKP, Zhang DX, Yip BHK, Cheng J, Hui SSC, Yu YTE, Leung M, Chu WCW, Milhailidou AS, Wong SYS. Exercise intervention to Normalize blood pressure and nocturnal Dipping in HyperTensive patients (END-HT): protocol of a randomized controlled trial. Am J Hypertens. 2021 Jan 20. pii: hpab019. doi: 10.1093/ajh/hpab019. [Epub ahead of print]

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Not yet recruiting
Estimated Enrollment  ICMJE
 (submitted: December 19, 2019)
198
Original Estimated Enrollment  ICMJE
 (submitted: April 18, 2019)
174
Estimated Study Completion Date  ICMJE December 31, 2023
Estimated Primary Completion Date September 30, 2023   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • SBP non-dippers
  • self-reported exercise intensity and duration less than the World Health Organization recommendation, which is exercise of moderate intensity less than 150minutes/week OR exercise of vigorous intensity of less than 75 minutes/week
  • Used any mobile apps on their phone (because the intervention involve use of apps to monitor and remind regular exercise)

Exclusion Criteria

  • Patients with diagnosed chronic obstructive lung disease and recent stroke (within last 12 months) because other evidence-proven and well-structured programmes are implemented for these patients in the hospital authority in Hong Kong
  • Occupational drivers - because they need to hold their arm still during ABPM and this may be hazardous for drivers

    • night-time workers
    • diagnosed Obstructive Sleep Apnea
  • Patients on anti-coagulants - because ABPM may induce bruises
  • Patients on 3 or more medications for hypertension (on maximum tolerable doses) - these patients may have secondary HT and represent a different spectrum of organic diseases
  • Patients with SBP >180mmHg or DBP >110mmHg - drug titration is not allowed during the 12-week program and these patients need early drug treatment
  • Patient with DM - these patients will be arranged to have another EIM program especially designed for their DM.

    • Patients with active spinal cord compression or spinal radiculopathy because they may not be suitable to join some exercise
    • patients with atrial fibrillation are excluded because these patients have increased BP variability and may have different dipping behaviour
    • patients with metallic implants or pacemakers are excluded as they are not suitable for MRI
  • To maximize safety of patients, patients who are relatively contraindicated according to AHA will also be excluded

    • acute myocardial infarction in last 6 months
    • ongoing angina
    • uncontrolled cardiac arrhythmia
    • acute diseases including known active endocarditis/acute pulmonary embolism, pulmonary infarction, deep vein thrombosis, acute aortic dissection, acute myocarditis
    • known aortic stenosis
    • known heart failure
    • known obstructive left main coronary artery stenosis
    • uncontrolled ventricular rates
    • complete heart block
    • known hypertrophic obstructive cardiomyopathy
    • mental impairment that limit co-operation
    • resting blood pressure with systolic blood pressure >180mmHg or diastolic blood pressure >110mmHg
    • known anemia with hemoglobin level less than 11gm/dL
    • known uncorrected electrolyte imbalance, and
    • known uncontrolled hyperthyroidism.
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years to 75 Years   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE
Contact: Kam Pui Lee, MSc 2252 8562 lkp032@cuhk.edu.hk
Listed Location Countries  ICMJE Hong Kong
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03923907
Other Study ID Numbers  ICMJE NTEC-2019-0264
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: Undecided
Plan Description: Will be made available on request from investigators
Responsible Party Lee Kam Pui, Chinese University of Hong Kong
Study Sponsor  ICMJE Chinese University of Hong Kong
Collaborators  ICMJE Not Provided
Investigators  ICMJE Not Provided
PRS Account Chinese University of Hong Kong
Verification Date January 2021

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP